Q1 2014 13F Holders as of 31 Mar 2014
-
Type / Class
-
Equity / Common stock, par value $0.0001 per share
-
Shares outstanding
-
58,272,553
-
Total 13F shares
-
20,545,950
-
Share change
-
+2,323,746
-
Total reported value
-
$804,373,483
-
Price per share
-
$39.15
-
Number of holders
-
73
-
Value change
-
+$93,802,312
-
Number of buys
-
45
-
Number of sells
-
26
Institutional Holders of AGIOS PHARMACEUTICALS, INC. - Common stock, par value $0.0001 per share (AGIO) as of Q1 2014
As of 31 Mar 2014,
AGIOS PHARMACEUTICALS, INC. - Common stock, par value $0.0001 per share (AGIO) was held by
73 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
20,545,950 shares.
The largest 10 holders included
Third Rock Ventures, LLC, Flagship Ventures 2007 General Partner LLC, FMR LLC, WELLINGTON MANAGEMENT CO LLP, VANGUARD GROUP INC, BlackRock Fund Advisors, FRANKLIN RESOURCES INC, EVENTIDE ASSET MANAGEMENT, LLC, LORD, ABBETT & CO. LLC, and Capital World Investors.
This page lists
73
institutional shareholders reporting positions in this security
for the Q1 2014 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.